Ideagen PLC Issue of Equity (7929E)
February 14 2018 - 2:00AM
UK Regulatory
TIDMIDEA
RNS Number : 7929E
Ideagen PLC
14 February 2018
Ideagen PLC
("Ideagen", "the Company" or the "Group")
Issue of shares under the Share Incentive Plan and Total Voting
Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
it has allotted a total of 5,625 new ordinary shares of 1 penny
each in the capital of the Company ("Ordinary Shares") following
the purchase of Ordinary Shares by a number of employees under the
Company's Share Incentive Plan ("SIP"). The new Ordinary Shares
were purchased at 115.5 pence each being the closing mid-market
share price on Thursday 8(th) February 2018.
Application has been made to the London Stock Exchange for the
5,625 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 19(th) February
2018.
After Admission, the total number of Ordinary Shares in issue
will be 200,228,920 and the total number of voting rights will
therefore be 200,228,920. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
Enquiries:
Ideagen plc 01629 699100
David Hornsby, Chief Executive
Graeme Spenceley, Finance Director
finnCap Limited 020 7220 0500
Stuart Andrews/Henrik Persson/James
Thompson (Nomad)
Stephen Norcross (Corporate
Broking)
About Ideagen plc
Ideagen is a UK company quoted on the London Stock Exchange AIM
market (Ticker: IDEA.L).
Ideagen is a supplier of Information Management software with
operations in the UK, the United States and the Middle East. The
Company specialises in GRC (Governance, Risk and Compliance) and
Content and Clinical solutions with a primary focus on
organisations operating within highly regulated industries. With an
excellent portfolio of software products, Ideagen is able to
provide complete information lifecycle solutions that enable
organisations to reduce risk, meet their regulatory and compliance
standards, helping them to reduce costs and improve efficiency.
The Group has a customer base of over 3,000 organisations using
the Ideagen suite of products, including many blue chip names such
as BAE Systems, Emirates, Shell and the European Central Bank as
well as 150 hospitals in the UK and US.
For further information please visit www.ideagen.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEBLGDDXSBBGIX
(END) Dow Jones Newswires
February 14, 2018 02:00 ET (07:00 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2024 to May 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From May 2023 to May 2024